PubRank

Intravitreal Dexamethasone vs Bevacizumab in Aboriginal People With DMO (OASIS)

Clinical Trial ID NCT04619303

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT04619303

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993 102.56
2 Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group. Arch Ophthalmol 1985 17.20
3 Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology 2010 10.28
4 A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study) 12-month data: report 2. Ophthalmology 2010 4.65
5 Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology 2011 4.15
6 Dexamethasone intravitreal implant for treatment of diabetic macular edema in vitrectomized patients. Retina 2011 3.04
7 Pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implant. Invest Ophthalmol Vis Sci 2011 2.53
8 Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research Group. Ophthalmology 1995 2.40
9 Randomized controlled trial of an intravitreous dexamethasone drug delivery system in patients with diabetic macular edema. Arch Ophthalmol 2010 1.82
10 Dexamethasone intravitreal implant for treatment of patients with persistent diabetic macular edema. Ophthalmologica 2013 1.82
11 Rates of progression in diabetic retinopathy during different time periods: a systematic review and meta-analysis. Diabetes Care 2009 1.55
12 Burden of illness of diabetic macular edema: literature review. Curr Med Res Opin 2010 1.39
13 Vision-related quality of life in patients with diabetic macular oedema. Br J Ophthalmol 2007 1.28
14 Results after lens extraction in patients with diabetic retinopathy: early treatment diabetic retinopathy study report number 25. Arch Ophthalmol 1999 1.23
15 Timing is everything: age of onset influences long-term retinopathy risk in type 2 diabetes, independent of traditional risk factors. Diabetes Care 2008 1.18
16 Intravitreal dexamethasone implant in patients with persistent diabetic macular edema. Ophthalmologica 2012 1.13
17 Five-month observation of persistent diabetic macular edema after intravitreal injection of Ozurdex implant. Mediators Inflamm 2014 0.90
18 Cost-effectiveness analysis of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology 2012 0.84
19 Clinical trials on corticosteroids for diabetic macular edema. World J Diabetes 2013 0.81
20 Prevalence of self-reported diabetes and diabetic retinopathy in indigenous Australians: the National Indigenous Eye Health Survey. Clin Experiment Ophthalmol 2011 0.81
21 Review of the prevalence of diabetic retinopathy in Indigenous Australians. Clin Experiment Ophthalmol 2014 0.81
22 Blood pressure control and diabetic retinopathy. Br J Ophthalmol 2002 0.77
23 Adjuvant treatment modalities to control macular edema in diabetic patients undergoing cataract surgery. Int Ophthalmol 2012 0.75
Next 100